Drugs / Nab-P
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06817525 Comparator | Nov 2024 → May 2026 overdue | triple-negative breast carcinoma | Henan Cancer Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nab-P | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06817525 ↗ |